AAI
MDCO

Aequim Alternative Investments’s Medicines Co MDCO Stock Holding History

Aequim Alternative Investments’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-176,600
Closed -$8.83M – 66
2019
Q3 		$8.83M Buy
+176,600
New +$7.04M 1.77% 17

Other funds holding MDCO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Aequim Alternative Investments's MDCO Position: Q4 2019 in Review

Aequim Alternative Investments sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 176,600 shares — an estimated $8.83M sold.

Aequim Alternative Investments first reported a position in MDCO in Q3 2019 and held it in 1 quarter. The position peaked at $8.83M in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Aequim Alternative Investments reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • Aequim Alternative Investments sold 176,600 Medicines Co shares in Q4 2019, an estimated $8.83M.
  • Aequim Alternative Investments first reported a position in Medicines Co in Q3 2019 and held it in 1 quarter.
  • Aequim Alternative Investments's Medicines Co position peaked at $8.83M in Q3 2019.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Aequim Alternative Investments's 13F filing for Q4 2019, filed 14 Feb 2020.